IN8BIO, INC. Annual Operating Income (Loss) in USD from 2020 to 2023

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
In8 Bio, Inc. quarterly/annual Operating Income (Loss) history and growth rate from 2020 to 2023.
  • In8 Bio, Inc. Operating Income (Loss) for the quarter ending September 30, 2024 was -$7.09M, a 1.16% increase year-over-year.
  • In8 Bio, Inc. Operating Income (Loss) for the twelve months ending September 30, 2024 was -$32.2M, a 6.61% decline year-over-year.
  • In8 Bio, Inc. annual Operating Income (Loss) for 2023 was -$30.3M, a 6.37% decline from 2022.
  • In8 Bio, Inc. annual Operating Income (Loss) for 2022 was -$28.5M, a 94.6% decline from 2021.
  • In8 Bio, Inc. annual Operating Income (Loss) for 2021 was -$14.7M, a 71.2% decline from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Annual (USD)
Operating Income (Loss), YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 -$30.3M -$1.82M -6.37% Jan 1, 2023 Dec 31, 2023 10-K 2024-03-14
2022 -$28.5M -$13.9M -94.6% Jan 1, 2022 Dec 31, 2022 10-K 2024-03-14
2021 -$14.7M -$6.1M -71.2% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-30
2020 -$8.56M Jan 1, 2020 Dec 31, 2020 10-K 2022-03-17
* An asterisk sign (*) next to the value indicates that the value is likely invalid.